SYNTASE Trademark
SYNTASE is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Pending.
Trademark Facts
| Mark | SYNTASE |
|---|---|
| Serial Number | 99421485 |
| Status | Pending |
| Filing Date | 2025-09-30 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 8 |
| Latest Event | PUBO on 2026-03-17 |
Goods & Services
Class 042: Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy; Research in the field of gene editing technology; Providing a gene editing platform for others to conduct pharmaceutical research and development in the field of in vivo gene editing therapy